probucol has been researched along with Cardiotoxicity in 1 studies
Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.
Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mooranian, A | 1 |
Zamani, N | 1 |
Takechi, R | 1 |
Luna, G | 1 |
Mikov, M | 1 |
Goločorbin-Kon, S | 1 |
Elnashar, M | 1 |
Arfuso, F | 1 |
Al-Salami, H | 1 |
1 other study available for probucol and Cardiotoxicity
Article | Year |
---|---|
An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques.
Topics: Administration, Oral; Animals; Capsules; Cardiotoxicity; Diabetes Mellitus, Experimental; Diabetes M | 2019 |